According to Tandem Diabetes Care 's latest financial reports and stock price the company's current Operating Margin is -25.16%. At the end of 2022 the company had an Operating Margin of -7.71%.
Year | Operating Margin | Change |
---|---|---|
2022 | -7.71% | -339.34% |
2021 | 3.22% | -302.07% |
2020 | -1.60% | -65.44% |
2019 | -4.62% | -80.99% |
2018 | -24.27% | -58.5% |
2017 | -58.50% | -36.86% |
2016 | -92.64% | -2.19% |
2015 | -94.72% | -37.76% |
2014 | -152.17% | -24.45% |
2013 | -201.43% | -83.65% |
2012 | -1,232.06% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -190.94% | ๐บ๐ธ USA |
Medtronic MDT | 17.17% | -168.24% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | -5.01% | -80.09% | ๐บ๐ธ USA |
DexCom DXCM | 13.43% | -153.38% | ๐บ๐ธ USA |
Insulet PODD | 0.75% | -102.98% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.